Guidelines for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder were published in 2019 by the American Academy of Pediatrics (AAP).
Any child or adolescent age 4 to 18 years who presents with academic or behavioral problems and symptoms of inattention, hyperactivity, or impulsivity should be evaluated for ADHD.
In evaluating a child or adolescent for ADHD, the primary care clinician (PCC) should screen for comorbid conditions, including emotional or behavioral conditions, developmental conditions, and physical conditions.
For preschool-aged children (ages 4 to 6 years) with ADHD, the PCC should prescribe evidence-based parent training in behavior management (PTBM) and/or behavioral classroom interventions as the first line of treatment.
If behavioral interventions don't work, methylphenidate may be considered.
For elementary and middle school-aged children (ages 6 to 12 years) with ADHD, the PCC should prescribe FDA-approved medications for ADHD, along with PTBM and/or behavioral classroom intervention.
For adolescents (ages 12 to 18 years) with ADHD, the PCC should prescribe FDA-approved medications for ADHD with the adolescent’s assent. The PCC is encouraged to prescribe evidence-based training interventions and/or behavioral interventions as well.
For more Clinical Practice Guidelines, go to Guidelines.
For more information, go to Attention-Deficit/Hyperactivity Disorder.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Attention-Deficit/Hyperactivity Disorder Clinical Practice Guidelines (AAP, 2019) - Medscape - Nov 04, 2019.